Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Jougasaki

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
The American Journal of Cardiology|July 15, 1993
Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectorisH Tanaka, H Yasue, M Yoshimura, et al.
The American Journal of Physiology|September 8, 1998
Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullinO Lisy, M Jougasaki, J A Schirger, et al.
The American Journal of Physiology|February 12, 1998
Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonismT E Rasmussen, M Jougasaki, T Supaporn, et al.
The American Journal of Physiology|November 15, 1997
Adrenomedullin in experimental congestive heart failure: cardiorenal activationM Jougasaki, T L Stevens, D D Borgeson, et al.
Circulation|February 1, 1993
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failureM Yoshimura, H Yasue, K Okumura, et al.
Circulation|July 1, 1993
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarctionE Morita, H Yasue, M Yoshimura, et al.
Journal of Cardiac Failure|September 21, 2000
Clinical criteria and biochemical markers for the detection of systolic dysfunctionK Yamamoto, J C Burnett, E A Bermudez, et al.
British Heart Journal|December 1, 1994
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failureM Yoshimura, H Yasue, H Tanaka, et al.
The American Journal of Physiology|April 11, 1995
Renal localization and actions of adrenomedullin: a natriuretic peptideM Jougasaki, C M Wei, L L Aarhus, et al.
Journal of the American College of Cardiology|November 18, 2000
Subcutaneous administration of brain natriuretic peptide in experimental heart failureH H Chen, J A Grantham, J A Schirger, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
The American Journal of Cardiology|July 15, 1993
Suppression of hyperventilation-induced attacks with infusion of atrial natriuretic peptide in patients with variant angina pectorisH Tanaka, H Yasue, M Yoshimura, et al.
The American Journal of Physiology|September 8, 1998
Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullinO Lisy, M Jougasaki, J A Schirger, et al.
The American Journal of Physiology|February 12, 1998
Cardiovascular actions of ET-B activation in vivo and modulation by receptor antagonismT E Rasmussen, M Jougasaki, T Supaporn, et al.
The American Journal of Physiology|November 15, 1997
Adrenomedullin in experimental congestive heart failure: cardiorenal activationM Jougasaki, T L Stevens, D D Borgeson, et al.
Circulation|February 1, 1993
Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failureM Yoshimura, H Yasue, K Okumura, et al.
Circulation|July 1, 1993
Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarctionE Morita, H Yasue, M Yoshimura, et al.
Journal of Cardiac Failure|September 21, 2000
Clinical criteria and biochemical markers for the detection of systolic dysfunctionK Yamamoto, J C Burnett, E A Bermudez, et al.
British Heart Journal|December 1, 1994
Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failureM Yoshimura, H Yasue, H Tanaka, et al.
The American Journal of Physiology|April 11, 1995
Renal localization and actions of adrenomedullin: a natriuretic peptideM Jougasaki, C M Wei, L L Aarhus, et al.
Journal of the American College of Cardiology|November 18, 2000
Subcutaneous administration of brain natriuretic peptide in experimental heart failureH H Chen, J A Grantham, J A Schirger, et al.
Pageof 6